§ COMPARE REGULATORS

PMDA vs COFEPRIS: Medical Device Regulatory Comparison

Compare the medical device registration pathways, classification, and regulatory requirements of PMDA (Japan) vs COFEPRIS (Mexico).

PMDA

Pharmaceuticals and Medical Devices Agency (Japan)

Japan

Japan's PMDA conducts scientific reviews of medical device applications under the PMD Act. Japan uses a four-class system with three pathways: Todokede (notification) for Class I, Ninsho (third-party

CLASSES

Class I, II, III, IV

PATHWAY

Todokede / Ninsho / Shonin

KEY FUNCTIONS
  • Shonin pre-market approval
  • Ninsho third-party certification
  • QMS inspection (MHLW Ordinance 169)
  • PMDA consultation (Taimen Joshu)
  • Foreign Manufacturer Registration

COFEPRIS

Federal Commission for Protection against Health Risks (Mexico)

Mexico

COFEPRIS regulates medical devices in Mexico under the General Health Law. Mexico uses a three-class system (I, II, III). A sanitary registration (registro sanitario) is required for Class II and III

CLASSES

Class I, II, III

PATHWAY

COFEPRIS sanitary registration

KEY FUNCTIONS
  • Sanitary registration
  • FDA/EU recognition pathway
  • GMP compliance
  • Import permits
  • Vigilance reporting

MedFlux monitors both PMDA and COFEPRIS in real time — every regulatory change, safety alert, and market signal delivered in under 90 seconds.

COMPARE LIVE DATA FREE →

§ OTHER COMPARISONS